Lyme disease

Clin Evid. 2002 Jun;(7):652-64.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Antigens, Surface / administration & dosage
  • Antigens, Surface / adverse effects
  • Bacterial Outer Membrane Proteins / administration & dosage
  • Bacterial Outer Membrane Proteins / adverse effects
  • Bacterial Vaccines
  • Bites and Stings / drug therapy
  • Humans
  • Lipoproteins*
  • Lyme Disease / diagnosis
  • Lyme Disease / drug therapy*
  • Lyme Disease / prevention & control
  • Lyme Neuroborreliosis / diagnosis
  • Lyme Neuroborreliosis / drug therapy*
  • Lyme Neuroborreliosis / prevention & control
  • Microbial Sensitivity Tests
  • Middle Aged
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Ticks
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antigens, Surface
  • Bacterial Outer Membrane Proteins
  • Bacterial Vaccines
  • Lipoproteins
  • OspA protein